NY State Senate Bill 2021-S8240

Archive: Last Bill Status - In Senate Committee Women's Issues Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Feb 07, 2022	referred to women's issues

2021-S8240 (ACTIVE) - Details

Current Committee:: Senate Women's Issues
Law Section:: Insurance Law
Laws Affected:: Amd §§3221, 4303 & 4322, Ins L
Versions Introduced in 2023-2024 Legislative Session:: S200

2021-S8240 (ACTIVE) - Summary

Relates to coverage of primary and preventative obstetric and gynecological care.

2021-S8240 (ACTIVE) - Sponsor Memo

                                 
BILL NUMBER: S8240

SPONSOR: CLEARE
 
TITLE OF BILL:

An act to amend the insurance law, in relation to coverage of primary
and preventative obstetric and gynecological care

 
PURPOSE OR GENERAL IDEA OF BILL:

This bill would require insurance coverage for annual cervical cytology
screening for cervical cancer without cost sharing and would require
insurance coverage for treatment of osteoporosis.

 
SUMMARY OF PROVISIONS:

The bill amends sections 3221(1) (14) and 4303(t) of the Insurance Law
to provide insurance coverage without cost sharing for an annual cervi-
cal cytology screening for cervical cancer and its precursor states for
women aged 18 and older. Such screenings shall include an annual pelvic
examination, collection and preparation of a Pap smear, and laboratory
and diagnostic services provided in connection with examining and evalu-

ating the Pap smear. The bill also amends § 3221(k)(13), 4303(bb), and
4322 of the Insurance Law to provide insurance coverage for the treat-
ment of osteoporosis.

 
JUSTIFICATION:

An annual screening for cervical cancer is essential to ensure prompt
treatment of cancer. The current law provides for coverage for these
screenings, but authorizes deductibles and coinsurance. The costs asso-
ciated with an annual examination results in cases of cervical cancer
not being diagnosed until a later stage, which lowers the rate for
successful treatment while increasing the costs associated with such
treatment. By eliminating the cost-sharing component of an annual cervi-
cal cytology screening, the bill would encourage women to undertake
annual screenings.

The current law also provides for coverage for bone marrow density meas-
urements and other test for the detection of osteoporosis. The bill
makes it clear that such policies would also be required to provide
coverage for the treatment of osteoporosis.

 
PRIOR LEGISLATIVE HISTORY:

2019-2020: A.6481 - referred to Insurance

 
FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS:

None.

 
EFFECTIVE DATE:
This act shall take effect on the sixtieth day after it shall have
become a law and shall apply to all policies, issued, renewed, modified
or altered on or after such date.

2021-S8240 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8240
 
                             I N  S E N A T E
 
                             February 7, 2022
                                ___________
 
 Introduced  by  Sen.  CLEARE -- read twice and ordered printed, and when
   printed to be committed to the Committee on Women's Issues
 
 AN ACT to amend the insurance law, in relation to  coverage  of  primary
   and preventative obstetric and gynecological care
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Subparagraph (C) of  paragraph  14  of  subsection  (l)  of
 section 3221 of the insurance law, as amended by chapter 219 of the laws
 of 2011, is amended to read as follows:
   (C) Such coverage required pursuant to subparagraph (A) or (B) of this
 paragraph  [may]  SHALL NOT be subject to annual deductibles and coinsu-
 rance [as may be deemed appropriate by the  superintendent  and  as  are
 consistent  with  those  established  for  other benefits within a given
 policy].
   § 2. Paragraph 1 of subsection (t) of section 4303  of  the  insurance
 law,  as  amended by chapter 219 of the laws of 2011, is amended to read
 as follows:
   (1) A medical expense indemnity corporation, a hospital service corpo-
 ration or a health service corporation that provides coverage for hospi-
 tal, surgical, or medical care shall  provide  coverage  for  an  annual
 cervical cytology screening for cervical cancer and its precursor states
 for  women aged eighteen and older. Such coverage required by this para-
 graph [may] SHALL NOT be subject to annual deductibles  and  coinsurance
 [as  may be deemed appropriate by the superintendent and as are consist-
 ent with those established for other benefits within a given contract].
   § 3. The opening paragraph  of  paragraph  13  of  subsection  (k)  of
 section 3221 of the insurance law, as amended by chapter 219 of the laws
 of 2011, is amended to read as follows:
   Every group or blanket policy delivered or issued for delivery in this
 state that provides major medical or similar comprehensive-type coverage
 shall  provide  such  coverage  for bone mineral density measurements or
 tests, and if such contract otherwise includes coverage for prescription
 drugs, drugs and devices approved by the federal food and drug  adminis-
 tration  or generic equivalents as approved substitutes.  In determining
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

                                                            LBD08660-01-1
 S. 8240                             2
 
 appropriate coverage provided by subparagraphs (A), (B) and (C) of  this
 paragraph,  the  insurer  or health maintenance organization shall adopt
 standards that include the criteria of the federal Medicare program  and
 the  criteria of the national institutes of health for the detection AND
 TREATMENT of osteoporosis, provided that such coverage shall be  further
 determined as follows:
   §  4.  The opening paragraph of subsection (bb) of section 4303 of the
 insurance law, as amended by chapter 219 of the laws of 2011, is amended
 to read as follows:
   A health service corporation or a medical  service  expense  indemnity
 corporation  that  provides  major medical or similar comprehensive-type
 coverage shall provide such coverage for bone mineral  density  measure-
 ments  or  tests,  and  if such contract otherwise includes coverage for
 prescription drugs, drugs and devices approved by the federal  food  and
 drug  administration  or generic equivalents as approved substitutes. In
 determining appropriate coverage provided by  paragraphs  one,  two  and
 three of this subsection, the insurer or health maintenance organization
 shall  adopt standards that include the criteria of the federal Medicare
 program and the criteria of the national institutes of  health  for  the
 detection  AND  TREATMENT  of  osteoporosis, provided that such coverage
 shall be further determined as follows:
   § 5. The second undesignated paragraph of paragraph 26  of  subsection
 (b)  of  section 4322 of the insurance law, as amended by chapter 219 of
 the laws of 2011, is amended to read as follows:
   In determining appropriate coverage provided by subparagraphs (A), (B)
 and (C) of this paragraph, the insurer or health  maintenance  organiza-
 tion  shall  adopt  standards  that  include the criteria of the federal
 Medicare program and the criteria of the national institutes  of  health
 for  the  detection  AND  TREATMENT  of osteoporosis, provided that such
 coverage shall be further determined as follows:
   § 6. This act shall take effect on the sixtieth  day  after  it  shall
 have become a law and shall apply to all policies issued, renewed, modi-
 fied or altered on or after such date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S8240

Sponsored By

Archive: Last Bill Status - In Senate Committee Women's Issues Committee

2021-S8240 (ACTIVE) - Details

2021-S8240 (ACTIVE) - Summary

2021-S8240 (ACTIVE) - Sponsor Memo

2021-S8240 (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S8240

Share this bill

Sponsored By

Cordell Cleare

Archive: Last Bill Status - In Senate Committee Women's Issues Committee

2021-S8240 (ACTIVE) - Details

2021-S8240 (ACTIVE) - Summary

2021-S8240 (ACTIVE) - Sponsor Memo

2021-S8240 (ACTIVE) - Bill Text download pdf

Comments